Clinical Trials · NCT01210144

EXpression PRofile Endometrium Samples Study

TerminatedPhase 4Gonadorelin (Prohibited)
Phase
Phase 4
Recruitment status
Terminated
Sponsor
Merck KGaA, Darmstadt, Germany
Enrollment
27
Start date
Aug 2008
Locations
1 site, France
Primary endpoint
Gene Expression of the Endometrium Following 1 Cycle With Gonal-f®
View Gonadorelin compound reference